Turn Market Noise Into Negotiating Power
Innovation doesn’t equal enterprise value. You can have a proven product, strong revenue, and loyal customers and still get undervalued if buyers can’t quickly grasp your worth.
At Legacy DNA, we help mid-market healthtech and pharmacy leaders clarify, quantify, and communicate their value so buyers, partners, and investors instantly understand why they’re worth more.
We help you:
Build a clear, defensible market position that commands premium multiples
Craft a valuation-ready growth narrative that buyers believe and investors trust
Align positioning, product, and proof so traction translates directly into enterprise value
Ready to turn clarity into traction? Book a Positioning & Valuation Diagnostic now and discover how premium buyers will really see your company.
When Strong Companies Get Undervalued
Even high-performing companies lose leverage when their story and strategy fall out of sync.
We help leadership teams correct:
Valuation discounts when performance outpaces perception
Message misalignment when marketing, sales, and leadership tell different stories
Growth plateaus when revenue grows but enterprise value stalls
Unleveraged proof when data and case studies aren’t packaged to influence acquirers, partners, or investors
Positioning isn’t a branding exercise. It’s a valuation lever that drives adoption, strengthens negotiating power, and accelerates premium exits.
Strategies Built for Healthcare Growth
We don’t stop at messaging workshops or brand decks.
We build market positioning and valuation frameworks that connect product impact, buyer adoption, customer alignment, and investor confidence.
For companies preparing for an acquisition or recapitalization event, our Exit Readiness Sprint™ ensures your story, assets, and leadership narrative align with investor expectations early, before due diligence begins.
The Positioning & Valuation Playbook
In as little as 90 days, we help your team:
Define where you win and why buyers should pay a premium
Sharpen your commercial story around data, differentiation, and defensible impact
Package proof and traction into a narrative that accelerates both adoption and valuation
Then we stay engaged to ensure your positioning turns into momentum, not just a deck.
Market Intelligence That Defines Opportunity
We combine qualitative and quantitative insight to create clarity and competitive advantage.
Competitive landscape and white space opportunity mapping: See how key players position, price, and message their offerings, and identify where you can lead, not just compete
Market sizing & segmentation: Quantify market potential, define high-value buyer segments, and uncover untapped growth opportunities to inform strategic expansion
Revenue and valuation levers: Analyze the external forces, growth drivers, and market signals that most influence enterprise value and exit outcomes
“Clarity is commercial, not cosmetic. The companies that win category leadership don’t just out-innovate. They out-communicate.”— Dr. Roxie Mooney, CEO, Legacy DNA
Positioning That Gains Traction
Category clarity: Define or redefine your market category so customers, partners, and investors "get it" fast
Buyer messaging: Align your story with the decision-makers who control access, adoption, and revenue
Adoption trigger strategy: Map the moments that move stakeholders from curiosity to commitment
“Positioning is the bridge between market potential and market performance.” — Harvard Business Review, 2024
A Valuation-Ready Growth Narrative
Investor & acquirer lens: Connect your commercial performance to defensible, repeatable value creation
Evidence packaging: Turn pilots, case studies, and clinical data into investor-grade proof that builds confidence
Exit-readiness insight: Understand what premium buyers look for and build toward it now with our Premium Acquisition Sprint™
“Private equity firms and strategics alike are rewarding clarity. Companies with aligned commercial stories and data-driven proof see 20–30% higher valuation multiples at exit.” — PitchBook, 2025
Execution Support for Real Market Momentum
We don’t just hand off strategy.
Legacy DNA coaches leadership, sales, and marketing teams to unify narrative, accelerate adoption, and track progress that ties directly to valuation impact.
For sustained growth beyond the initial sprint, our Healthcare Growth Engine Partnership™ embeds commercialization leadership to ensure your positioning continues to drive adoption and enterprise value long after the first 90 days.
Turning Late Entrants Into Market Leaders
Real-World Impact: ParcelShield
When ParcelShield, an AI-enabled healthcare logistics company, entered the market, it faced a dominant competitor, limited visibility, and valuation skepticism.
Legacy DNA developed a unique and compelling brand story, market positioning, and value messaging that captured attention and created demand for the company’s solution. The repositioning transformed a late entrant into a formidable competitor. The shift was so significant that incumbent competitors united under one company, and together they became an attractive acquisition target for private equity.
The result:
A 23% market share gain within 18 months
A private equity acquisition that reshaped the healthcare logistics category
From Clarity to Market Impact: How We Build Your Growth Story
Our process provides clarity, proof, and activation, giving buyers, partners, and investors a unified, credible reason to believe.
How the Process Works
Diagnose & Align – We identify what’s blocking growth and valuation through a market readiness diagnostic
Clarify Customers & Value – Define high-value audiences and craft narratives that resonate with buyers, partners, and investors
Build Your Market & Valuation Story – Shape your category, unify your brand narrative, and package the proof buyers expect
Activate & Scale – Deploy your positioning across GTM, sales, and investor communications to drive measurable traction and valuation
Frequently Asked Questions
-
We partner with mid-market healthtech and pharmacy CEOs and founders, often PE-backed, scaling beyond $50M and preparing for an exit within 12–36 months.
-
We apply the full science of commercialization that aligns brand, go-to-market, demand generation, and sales enablement to increase enterprise value, not vanity metrics.
-
Tangible growth assets that accelerate traction and de-risk your exit, including persona packs, messaging frameworks, valuation dashboards, and investor-ready narratives.
-
Our clients have scaled from $50M to $500M and $750M to $2B, achieving multiple premium exits. Every deliverable ties back to valuation impact
-
Yes. We partner with PE operating teams to de-risk portfolio exits, sharpen GTM narratives, and embed commercialization leadership without adding full-time overhead.
-
Absolutely. We complement internal teams with executive-level strategy and frameworks, freeing them to execute with clarity and precision.
-
Many start with a 90-day sprint to gain immediate clarity and assets, then expand into a 12-month partnership to sustain and maximize valuation moment
-
We work across specialty pharmacy, infusion, PBMs, digital health, and medtech, focusing on companies at scale or approaching transaction events.
-
If you’re a mid-market CEO or PE partner preparing for a premium exit, under pressure to scale, or struggling to align brand, demand, and valuation, we can help.
-
Most leaders begin with a Sprint, a focused 90-day engagement that delivers enterprise-ready assets and valuation clarity. From there, we scale into a long-term growth partnership.
Tell a Clear, Compelling Story That Opens Doors
Your team has built something extraordinary. It deserves to be valued that way. It needs a valuation strategy that strengthens credibility, expands market leadership, and commands premium multiples.
With Legacy DNA, you’ll:
Turn market clarity into negotiating leverage
Translate commercial performance into defensible valuation gains
Build the narrative and assets that drive premium multiples at exit
Ready to command a premium exit?
This small, independent specialty pharmacy wanted to dance with the giants, but first, they needed to find their rhythm. Armed with stronger branding, positioning, and thought leadership, they learned new routines. It wasn’t long before they could jump on the dance floor and hustle their way to explosive growth (968% in one decade), taking their pharmacy from millions to billions.
Embracing a paradigm shift from traditional marketing, this tech platform undertook a comprehensive overhaul. Using more strategic go-to-market processes, they ushered their specialty pharmacy innovations into the modern era. Today, they continue to lead the way with their pioneering reputation and forge a path towards a more transformative future.
Armed with firsthand insights and feedback from numerous patients, this physician had a uniquely clear vision of the market's requirements. The problem was that he was up against a saturated landscape commanded by well-established household brands with deep pockets and enduring customer loyalty. The challenge lay in carving a distinctive niche. Leveraging a dynamic and robust commercialization strategy along with a bold brand identity, his product managed to not only capture the spotlight but also secure coveted shelf space within prominent big-box retailers.
It’s easy to coast along when you’re making a profit in an industry that’s full of growth and opportunity. But this independent pharmacy buying group wanted to take it to the next level. With a robust strategic marketing plan and by leveraging modern tools, tactics, and best practices, they were able to drive rapid growth and transform into an online destination for independent pharmacy owners.
With a lean team and limited resources, this company harnessed a late-entrant advantage, crafting an ingenious brand strategy that utilized a SaaS model and AI to creatively exploit the gaps left by dominant market players. The result? They were not only able to compete against industry giants, they went on to absorb their top competitor in just two years, reshaping the market landscape.
In an industry barreling toward commoditization, this specialty pharmacy recognized the urgency of setting itself apart. Through a blend of enhanced, strategic branding and impactful messaging, they were able to secure their market position in the hearts and minds of patients and stakeholders, making them a desirable target for acquisition.
This specialty pharmacy built a strong name for itself in the HCV field - but struggled to stay visible in a saturated market. Leadership knew marketing resources were stretched thin, and they had no real strategic plan in place, but the market was experiencing massive growth. Capitalizing on that growth meant they needed a plan - a marketing plan. Two years later, with a strategic marketing plan and enhanced foundational assets in place, their net worth soared from $50 million to $500 million, making them an irresistible acquisition for the fifth-largest pharmacy in the United States.
This digital health startup set out to develop an early adoption strategy and a clear path to market. While developing the strategies that would help them avoid pitfalls, circumvent failure, and recognize opportunities, COVID hit. Armed with their newly acquired early adoption vision, they were able to confidently perform a powerful pandemic pivot to success.
